Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates.

Gallagher, Molly E; Sieben, Andrew J; Nelson, Kristin N; Kraay, Alicia N M; Orenstein, Walter A; Lopman, Ben; Handel, Andreas; Koelle, Katia

Gallagher, Molly E; Sieben, Andrew J; Nelson, Kristin N; Kraay, Alicia N M; Orenstein, Walter A; Lopman, Ben; Handel, Andreas; Koelle, Katia.

Afiliação

Gallagher ME; Department of Biology, Emory University, Atlanta, GA, USA. mgallagher@emory.edu.
Sieben AJ; School of Medicine, Emory University, Atlanta, GA, USA.
Nelson KN; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Kraay ANM; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Orenstein WA; Emory Vaccine Center, School of Medicine, Emory University, Atlanta, GA, USA.
Lopman B; Emory-UGA Center of Excellence of Influenza Research and Surveillance, Atlanta, GA, USA.
Handel A; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Koelle K; Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, GA, USA.

Nat Med ; 27(1): 4-5, 2021 01.

Article em En | MEDLINE | ID: mdl-33230343

Assuntos

Vacinas contra COVID-19/administração & dosagem; COVID-19/prevenção & controle; SARS-CoV-2/fisiologia; Pesquisa Biomédica; COVID-19/economia; COVID-19/virologia; Vacinas contra COVID-19/efeitos adversos; Humanos; Resultado do Tratamento

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google